Cell Cycle Variants and Metastatic Prostate Cancer Risk

Principal Investigator

Name
Adam Kibel

Degrees
-

Institution
Washington University

Position Title
-

Email
akibel@partners.org

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
2005-0001

Initial CDAS Request Approval
Aug 17, 2005

Title
Cell Cycle Variants and Metastatic Prostate Cancer Risk

Summary
Please see paper application

Aims

Please see paper application

Collaborators

Brian Suarez (WUSM/Psychiatry)
Richard Hayes (NCI, DCEG)
Howard McLeod (WUSM/Pharm)
Kibel Adam (Washington University - School of Medicine)
Robert D. Burk (Albert Einstein College of Medicine)
Tao Wang (Albert Einstein College of Medicine)
William Isaacs (JHMI/Urology)
Yan Yan (WUSM/Urology)

Related Publications

• Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
  Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW
  The Prostate. 2016 Apr; Volume 76 (Issue 5): Pages 479-90 PUBMED